Log In
Print this Print this

Undisclosed HuCal antibody for ophthalmology

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionUndisclosed antibody developed using MorphoSys' HuCAL GOLD library
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat ophthalmic disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today